# Whitehawk Therapeutics, Inc.: Form SCHEDULE 13D/A, filed May 18, 2026

- Company: [Whitehawk Therapeutics, Inc.](/companies/whwk.md) (CIK 1422142)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-18
- Accepted by EDGAR: May 18, 2026, 19:03 ET
- Period: not reported
- Accession: 0000935836-26-000289
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1422142/000093583626000289/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422142/000093583626000289/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422142/000093583626000289/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 18, 2026.
Source: SEC EDGAR, the filing index for accession 0000935836-26-000289. Last ingested by Listed: Nov 15, 2026, 04:20 ET. No prices; not investment advice.
